Hemosol B0 solution for haemodialysis/haemofiltration
*Company:
Baxter Holding B.V.Status:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 13 March 2024
File name
ie-spc-2024-02-hemosolb0-2299051002-c.pdf
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 27 February 2024
File name
ie-spc-2023-03-hemosolb0-2299051002-c.pdf
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 07 August 2023
File name
Hemosol UK.IE.MT CB3002715_15FEB2022_P03.pdf
Reasons for updating
- New PIL for new product
Updated on 24 January 2023
File name
ie_spc_Hemosol B0_PA2299-051-002_April 2021.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 19 April 2021
File name
ie_spc_Hemosol B0_PA2299-051-002_April 2021.pdf
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 16 December 2020
File name
ie_spc_Hemosol B0_PA2299-051-002_Dec 2020.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 27 March 2019
File name
ie-spc-2019-03-hemosolb0-785005002-c.pdf
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 17 October 2017
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 17 October 2017
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 3 - Pharmaceutical form
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to section 4.9 - Overdose
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 6.5 - Nature and contents of container
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Modification of the SmPC sections 2, 3, 4.2, 4.4, 4.5, 4.6, 4.8, 4.9, 5.1, 6.5, 6.6, 7 and 10
Section 2 - removal of text - Theoretical Osmolarity 287 mOsm/1
Section 3 - removal of text - Theoretical Osmolarity 287 mOsm/1
Section 4.2 major change in text
Section 4.4 major change in text
Section 4.5 major change in text
Section 4.6 addition of text - Pregnancy and breastfeeding and Fertility - There are no clinical data on fertility. However no effects on fertility are anticipated
Section 4.8 major changes in text and addition of a table
Section 4.9 major text changes
Section 5.1 addition of two headings - Pharmacodynamic effects and Mechanism of action - deletion of the work Bicarbonate under heading Mechanism of action
Section 6.5 deletion of text frangible pin (PC) or
Section 6.6 major text changes
Section 7 - address change
Section 10 date change
Section 2 - removal of text - Theoretical Osmolarity 287 mOsm/1
Section 3 - removal of text - Theoretical Osmolarity 287 mOsm/1
Section 4.2 major change in text
Section 4.4 major change in text
Section 4.5 major change in text
Section 4.6 addition of text - Pregnancy and breastfeeding and Fertility - There are no clinical data on fertility. However no effects on fertility are anticipated
Section 4.8 major changes in text and addition of a table
Section 4.9 major text changes
Section 5.1 addition of two headings - Pharmacodynamic effects and Mechanism of action - deletion of the work Bicarbonate under heading Mechanism of action
Section 6.5 deletion of text frangible pin (PC) or
Section 6.6 major text changes
Section 7 - address change
Section 10 date change
Updated on 17 October 2017
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 3 - Pharmaceutical form
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to section 4.9 - Overdose
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 6.5 - Nature and contents of container
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
Modification of the SmPC sections 2, 3, 4.2, 4.4, 4.5, 4.6, 4.8, 4.9, 5.1, 6.5, 6.6, 7 and 10
Section 2 - removal of text - Theoretical Osmolarity 287 mOsm/1
Section 3 - removal of text - Theoretical Osmolarity 287 mOsm/1
Section 4.2 major change in text
Section 4.4 major change in text
Section 4.5 major change in text
Section 4.6 addition of text - Pregnancy and breastfeeding and Fertility - There are no clinical data on fertility. However no effects on fertility are anticipated
Section 4.8 major changes in text and addition of a table
Section 4.9 major text changes
Section 5.1 addition of two headings - Pharmacodynamic effects and Mechanism of action - deletion of the work Bicarbonate under heading Mechanism of action
Section 6.5 deletion of text frangible pin (PC) or
Section 6.6 major text changes
Section 7 - address change
Section 10 date change
Section 2 - removal of text - Theoretical Osmolarity 287 mOsm/1
Section 3 - removal of text - Theoretical Osmolarity 287 mOsm/1
Section 4.2 major change in text
Section 4.4 major change in text
Section 4.5 major change in text
Section 4.6 addition of text - Pregnancy and breastfeeding and Fertility - There are no clinical data on fertility. However no effects on fertility are anticipated
Section 4.8 major changes in text and addition of a table
Section 4.9 major text changes
Section 5.1 addition of two headings - Pharmacodynamic effects and Mechanism of action - deletion of the work Bicarbonate under heading Mechanism of action
Section 6.5 deletion of text frangible pin (PC) or
Section 6.6 major text changes
Section 7 - address change
Section 10 date change
Updated on 10 January 2017
Reasons for updating
- New SPC for medicines.ie
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
None provided
Updated on 10 January 2017
Reasons for updating
- New SPC for medicines.ie
Free text change information supplied by the pharmaceutical company
None provided